A revolution in HCV treatment with direct-acting antivirals: From non-response to eradication-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A revolution in HCV treatment with direct-acting antivirals: From non-response to eradication

Published:2012-08 Issue:2 Volume:57 Page:455-457
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Asselah Tarik

Publisher

Elsevier BV

Subject

Hepatology

Reference15 articles.

1. Telaprevir for retreatment of HCV infection;Zeuzem;N Engl J Med,2011

2. Boceprevir for previously treated chronic HCV genotype 1 infection;Bacon;N Engl J Med,2011

3. Direct acting antivirals for the treatment of chronic hepatitis C: one pill a day for tomorrow;Asselah;Liver Int,2012

4. Oral combination therapy with a nucleoside polymerase inhibitor (RG7128) and danoprevir for chronic hepatitis C genotype 1 infection (INFORM-1): a randomised, double-blind, placebo-controlled, dose-escalation trial;Gane;Lancet,2010

5. Preliminary study of two antiviral agents for hepatitis C genotype 1;Lok;N Engl J Med,2012

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interleukin 28A.rs12980602 and interleukin 28B.rs8103142 genotypes could be protective against HCV infection among Egyptians;Immunologic Research;2018-11-06

2. KIR2DL2/C1 is a Risk Factor for Chronic Infection and Associated with Non-response to PEG-IFN and RBV Combination Therapy in Hepatitis C Virus Genotype 1b Patients in China;Virologica Sinica;2018-07-23

3. Global elimination of hepatitis C virus infection: Progresses and the remaining challenges;World Journal of Hepatology;2017-11-28

4. Influence of IFNL3.rs12979860 and IFNL4.ss469415590 polymorphism on clearance of hepatitis C virus infection among Egyptians;Hepatology International;2015-03-12

5. Use of ursodeoxycholic acid in patients with hypertransaminasemia;Italian Journal of Medicine;2014-09-18

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3